Platinum Investment Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,044
| Closed | -$930K | – | 135 |
|
|
2022
Q1 | $930K | Hold |
20,044
| – | – | 0.03% | 103 |
|
|
2021
Q4 | $1.42M | Hold |
20,044
| – | – | 0.04% | 104 |
|
|
2021
Q3 | $2.34M | Hold |
20,044
| – | – | 0.07% | 94 |
|
|
2021
Q2 | $3.14M | Hold |
20,044
| – | – | 0.07% | 79 |
|
|
2021
Q1 | $3.8M | Sell |
20,044
-2,402
| -11% | -$455K | 0.08% | 65 |
|
|
2020
Q4 | $2.82M | Buy |
22,446
+7,355
| +49% | +$923K | 0.06% | 75 |
|
|
2020
Q3 | $1.64M | Hold |
15,091
| – | – | 0.04% | 87 |
|
|
2020
Q2 | $1.81M | Sell |
15,091
-1,218
| -7% | -$146K | 0.04% | 90 |
|
|
2020
Q1 | $1.64M | Buy |
16,309
+3,307
| +25% | +$332K | 0.04% | 76 |
|
|
2019
Q4 | $3.15M | Sell |
13,002
-3,401
| -21% | -$825K | 0.06% | 53 |
|
|
2019
Q3 | $2.69M | Buy |
16,403
+2,243
| +16% | +$368K | 0.06% | 53 |
|
|
2019
Q2 | $3.34M | Buy |
14,160
+1,013
| +8% | +$239K | 0.08% | 48 |
|
|
2019
Q1 | $3.46M | Sell |
13,147
-1,167
| -8% | -$307K | 0.08% | 49 |
|
|
2018
Q4 | $1.31M | Buy |
14,314
+9,708
| +211% | +$885K | 0.04% | 68 |
|
|
2018
Q3 | $885K | Buy |
4,606
+1,481
| +47% | +$285K | 0.03% | 79 |
|
|
2018
Q2 | $675K | Buy |
+3,125
| New | +$675K | 0.02% | 79 |
|